Európska únia - slovenčina - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfóm, mantle-cell - antineoplastické činidlá - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

panpharma, francúzsko - suxametónium - 63 - myorelaxantia

Slovensko - slovenčina - myHealthbox

bayer ag - stabilna suspenzia - metalaxyl 20 g/l; prothioconazole 100 g/l

Slovensko - slovenčina - myHealthbox

bayer ag - suspenzný koncentrát - fluopicolide 200 g/l; fluoxastrobin 150 g/l

Slovensko - slovenčina - myHealthbox

bayer ag - stabilna suspenzia - metalaxyl 20 g/l; prothioconazole 100 g/l

Slovensko - slovenčina - myHealthbox

bayer ag - suspenzný koncentrát - fluopicolide 200 g/l; fluoxastrobin 150 g/l